AAAAAA

   
Results: 1-9 |
Results: 9

Authors: THOMAS WS NEALBELIVEAU BS JOYCE JN
Citation: Ws. Thomas et al., THERE IS A LIMITED CRITICAL PERIOD FOR DOPAMINES EFFECTS ON D1 RECEPTOR EXPRESSION IN THE DEVELOPING RAT NEOSTRIATUM, Developmental brain research, 111(1), 1998, pp. 99-106

Authors: NEALBELIVEAU BS JOYCE JN
Citation: Bs. Nealbeliveau et Jn. Joyce, BEHAVIORAL RESPONSITIVITY TO DOPAMINE-RECEPTOR AGONISTS AFTER EXTENSIVE STRIATAL DOPAMINE LESIONS DURING DEVELOPMENT, Developmental psychobiology, 32(4), 1998, pp. 313-326

Authors: FROHNA PA NEALBELIVEAU BS JOYCE JN
Citation: Pa. Frohna et al., DELAYED PLASTICITY OF THE MESOLIMBIC DOPAMINE SYSTEM FOLLOWING NEONATAL 6-OHDA LESIONS, Synapse, 25(3), 1997, pp. 293-305

Authors: JOYCE JN FROHNA PA NEALBELIVEAU BS
Citation: Jn. Joyce et al., FUNCTIONAL AND MOLECULAR DIFFERENTIATION OF THE DOPAMINE SYSTEM INDUCED BY NEONATAL DENERVATION, Neuroscience and biobehavioral reviews, 20(3), 1996, pp. 453-486

Authors: FROHNA PA NEALBELIVEAU BS JOYCE JN
Citation: Pa. Frohna et al., NEONATAL 6-HYDROXYDOPAMINE LESIONS LEAD TO OPPOSING CHANGES IN THE LEVELS OF DOPAMINE-RECEPTORS AND THEIR MESSENGER-RNAS, Neuroscience, 68(2), 1995, pp. 505-518

Authors: NEALBELIVEAU BS YANKE B JOYCE JN
Citation: Bs. Nealbeliveau et al., NEONATAL STRIATAL DOPAMINE LESIONS - BEHAVIORAL-EFFECTS ARE DEPENDENTUPON DEGREE OF DEPLETION, Developmental psychobiology, 28(3), 1995, pp. 192-192

Authors: FROHNA PA NEALBELIVEAU BS JOYCE JN
Citation: Pa. Frohna et al., NEONATAL 6-OHDA LESIONS UP-REGULATE ADULT EXPRESSION OF TYROSINE-HYDROXYLASE MESSENGER-RNA, NeuroReport, 4(9), 1993, pp. 1095-1098

Authors: NEALBELIVEAU BS JOYCE JN
Citation: Bs. Nealbeliveau et Jn. Joyce, D(1) AND D(2) DOPAMINE-RECEPTORS DO NOT UP-REGULATE IN RESPONSE TO NEONATAL INTRASTRIATAL 6-HYDROXYDOPAMINE LESIONS, Neuroscience letters, 160(1), 1993, pp. 77-80

Authors: NEALBELIVEAU BS JOYCE JN LUCKI I
Citation: Bs. Nealbeliveau et al., SEROTONERGIC INVOLVEMENT IN HALOPERIDOL-INDUCED CATALEPSY, The Journal of pharmacology and experimental therapeutics, 265(1), 1993, pp. 207-217
Risultati: 1-9 |